Open AccessImmune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes
Author(s) -
Aanika Balaji,
Jiajia Zhang,
Beatriz Wills,
Kristen A. Marrone,
Hany Elmariah,
Mark Yarchoan,
Jacquelyn W. Zimmerman,
Khalid Hajjir,
Deepti Venkatraman,
Deborah K. Armstrong,
Daniel A. Laheru,
Ranee Mehra,
Won Jin Ho,
Joshua E. Reuss,
Joseph Heng,
Paz J. Vellanki,
Ross C. Donehower,
Matthias Holdhoff,
Jarushka Naidoo
Publication year - 2019
Publication title -
journal of oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.555
H-Index - 60
eISSN - 1935-469X
pISSN - 1554-7477
DOI - 10.1200/jop.18.00703
Subject(s) - medicine , adverse effect , odds ratio , emergency medicine , pediatrics
Immune checkpoint inhibitors (ICIs) cause immune-related adverse events (irAEs). The proportion of patients who are hospitalized for irAEs and their spectrum, management, and outcomes are not well described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom